FAKTOR-OPTIONSSCHEIN - VETOQUINOL | Market Closed - Börse Stuttgart 06:17:48 2024-05-17 EDT | ||
| 9.55 EUR | -3.54% |
|
| Current month | -11.25% | ||
| 1 month | -7.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
VETOQUINOL SA
Latest news about VETOQUINOL SA
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 9.55 | -3.54% |
| 24-05-16 | 9.9 | +0.81% |
| 24-05-15 | 9.82 | -2.48% |
| 24-05-14 | 10.07 | -0.59% |
| 24-05-13 | 10.13 | +1.10% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 06:17 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | VETOQUINOL SA |
| Issuer | Morgan Stanley |
| WKN | MG1JF2 |
| ISIN | DE000MG1JF26 |
| Date issued | 2024-04-03 |
| Strike | 148.9 € |
| Maturity | Unlimited |
| Parity | 5.07 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.2 € |
|---|---|
| Lowest since issue | 9.55 € |
Company Profile
Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pets (67.7% of net sales; dogs, cats, etc.) and livestock (32.3%; cattle, pigs, poultry, etc.). The group's activity is organized around 4 product families:
- antibiotics;
- anti-inflammatories;
- cardiology and nephrology treatments;
- other: anti-parasitics, vaccines, and nutritional products.
At the end of 2022, the group had 5 production sites throughout the world.
Net sales are distributed geographically as follows: Europe (46.7%), the Americas (36%) and Asia/Pacific (17.3%).
Sector
-
Consensus: Vetoquinol SA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
101.2
EUR
Average target price
105.7
EUR
Spread / Average Target
+4.41%
- Stock Market
- Certificates
- Certificat
